| __timestamp | Axsome Therapeutics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 2242216 |
| Thursday, January 1, 2015 | 6776987 | 4536244 |
| Friday, January 1, 2016 | 21199860 | 5184803 |
| Sunday, January 1, 2017 | 19957616 | 3068742 |
| Monday, January 1, 2018 | 23495055 | 7178000 |
| Tuesday, January 1, 2019 | 53647067 | 16267000 |
| Wednesday, January 1, 2020 | 70244579 | 23191000 |
| Friday, January 1, 2021 | 58060725 | 21453000 |
| Saturday, January 1, 2022 | 57947447 | 15265000 |
| Sunday, January 1, 2023 | 97944000 | 25189000 |
| Monday, January 1, 2024 | 187077000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Axsome Therapeutics, Inc. and Soleno Therapeutics, Inc. have shown distinct strategies in their R&D allocations over the past decade.
Since 2014, Axsome Therapeutics has increased its R&D spending by over 2,000%, peaking in 2023 with a staggering 98 million dollars. This aggressive investment reflects their strategic focus on developing novel therapies for central nervous system disorders.
Conversely, Soleno Therapeutics has maintained a more conservative growth trajectory, with R&D expenses rising by approximately 1,000% over the same period. Their focus remains on rare genetic disorders, with a notable increase in spending in 2023, reaching 25 million dollars.
These contrasting strategies highlight the diverse approaches within the biotech sector, where innovation and financial prudence must be carefully balanced.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.